Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002457200 | SCV002615432 | pathogenic | Hereditary cancer-predisposing syndrome | 2017-11-22 | criteria provided, single submitter | clinical testing | The c.345_352delTTCTGGGAinsAGCC pathogenic mutation, located in coding exon 3 of the TP53 gene, results from the deletion of 8 nucleotides and insertion of 4 nucleotides causing a translational frameshift with a predicted alternate stop codon (p.H115Qfs*7). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |